Olympiad Research’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

Olympiad Research’s Portfolio KDNY Stock Details KDNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-38,931	Closed	-$1.5M	–	427
2023 Q2	$1.5M	Buy	+38,931	New	+$1,000K	1.47%	11

Olympiad Research's KDNY Position: Q3 2023 in Review

Olympiad Research sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2023, closing a stake of 38,931 shares — an estimated $1.5M sold.

Olympiad Research first reported a position in KDNY in Q2 2023 and held it in 1 quarter. The position peaked at $1.5M in Q2 2023. 2 funds tracked by Wall St. Rank hold KDNY as of Q3 2023.

Olympiad Research reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Olympiad Research sold 38,931 Chinook Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.5M.
Olympiad Research first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Olympiad Research's Chinook Therapeutics, Inc. Common Stock position peaked at $1.5M in Q2 2023.
2 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Olympiad Research's 13F filing for Q3 2023, filed 2 Nov 2023.